% | $
Quotes you view appear here for quick access.

ONYX Pharmaceuticals, AŞ Message Board

  • johnpapas893 johnpapas893 Oct 26, 2012 8:10 PM Flag

    revenue estimates

    Are there any estimates for the Nexavar and Kyprolis revenues?

    A few days ago S&P started coverage with a buy rating and PT of 105. Today the Maxim Group increased its PT from $95 to $105. And yet, the price declined from $93 to below $80 in approximately one week.

    Perhaps the old-timers of this board could provide some reassuring guidance.

    Sentiment: Strong Buy